<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01093443</url>
  </required_header>
  <id_info>
    <org_study_id>2009/196</org_study_id>
    <nct_id>NCT01093443</nct_id>
  </id_info>
  <brief_title>Gonadotropin-releasing Hormone (GnRH) Antagonist During 3 Days</brief_title>
  <official_title>Administration of a GnRH Antagonist During 3 Days at Initiation of the Cycle: Impact on the Stimulation in IVF/ICSI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective study, the investigators would like to show whether ovarian stimulation
      with pretreatment of a GnRH antagonist during 3 consecutive days at initiation of the cycle,
      is possible.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A recently accepted study demonstrated that raised progesterone levels can be normalized
      through administration of a GnRH antagonist during three subsequent days prior to the start
      of gonadotropin stimulation in a GnRH antagonist protocol. This regimen, after normalisation
      of the progesterone value, allows controlled ovarian hyperstimulation (COH). Since this
      regimen is valid in case of elevated progesterone, GnRH antagonists pretreatment may prove to
      be a valid tool for scheduling IVF treatment in patients with normal progesterone values on
      day 2 of the cycle. In this prospective randomised trial, the investigators study the impact
      of administration of a GnRH antagonist during 3 consecutive days at initiation of the cycle.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endocrine profile</measure>
    <time_frame>up to 9 months</time_frame>
    <description>The purpose is to assess the endocrine profile in each treatment group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>up to 9 months</time_frame>
    <description>The purpose is to study the pregnancy rate in each treatment group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients undergo a standard treatment with a classical GnRH antagonist protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Before undergoing a standard protocol for ovarian stimulation, patients in this group receive a pretreatment with GnRH antagonists during 3 consecutive days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ovarian stimulation</intervention_name>
    <description>rFSH with GnRH antagonists</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ovarian stimulation</intervention_name>
    <description>GnRH antagonist, rFSH, GnRH antagonist</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt; 39 years old on day of randomisation

          -  FSH &lt; 12 (in the early follicular phase)

          -  Normal ultrasound scan, i.e. presence of both ovaries, without evidence of abnormality
             within 6 months prior to randomisation.

          -  Regular menstrual cycles of 21-35 days, presumed to be ovulatory.

          -  BMI between 18 and 29 (both inclusive)

          -  1st or 2nd trial

          -  IVF or ICSI

          -  Randomisation at out-patient clinic

        Exclusion Criteria:

          -  ≥ 39 years old on day of randomisation

          -  Endometriosis ≥ grade 3

          -  PCOS
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UZ Brussel</name>
      <address>
        <city>Jette</city>
        <state>Brussels</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2010</study_first_submitted>
  <study_first_submitted_qc>March 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2010</study_first_posted>
  <last_update_submitted>October 8, 2010</last_update_submitted>
  <last_update_submitted_qc>October 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Paul Devroey</name_title>
    <organization>Universitair Ziekenhuis Brussel</organization>
  </responsible_party>
  <keyword>IVF</keyword>
  <keyword>ICSI</keyword>
  <keyword>GnRH antagonist</keyword>
  <keyword>pretreatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

